Beximco Pharmaceuticals (LON:BXP) Shares Down 6.7% – Time to Sell?

Beximco Pharmaceuticals Limited (LON:BXP)’s stock price fell 6.7% during mid-day trading on Thursday . The stock traded as low as GBX 42.77 and last traded at GBX 46.67. Approximately 386,473 shares traded hands during mid-day trading, an increase of 152% from the average daily volume of 153,287 shares. The stock had previously closed at GBX 50.

Beximco Pharmaceuticals Trading Down 6.7%

The firm has a market capitalization of £208.22 million, a P/E ratio of 0.03 and a beta of 0.61. The business’s 50 day moving average is GBX 42.86 and its two-hundred day moving average is GBX 42.70. The company has a quick ratio of 0.37, a current ratio of 4.13 and a debt-to-equity ratio of 5.27.

Beximco Pharmaceuticals Company Profile

Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.